Research Unit on Asymmetric Synthesis news

<p>The image shows a metastatic colon tumour infiltrated by the immune system (brown) after combined treatment with the TGF-beta inhibitor and immunotherapy.  (Author: Daniele Tauriello, IRB Barcelona)</p>
14 Feb 2018

A team headed by ICREA researcher Eduard Batlle discovers that immune system-stimulating treatments combined with a TGF-beta inhibitor are effective against colon cancer.

The researchers developed a mouse model that mimics advanced human colon cancer. This model has allowed them to study the immune system response for the first time.

<p>Depicted above, (+)-ryanodol is a derivate of a natural compound with intracellular calcium-regulating capacity</p>
12 Sep 2016

The journal Science publishes a commentary article on the Pauson-Khand reaction made by an expert at IRB Barcelona

<p>Alessandro Ruffoni is an Italian pharmaceutical chemist</p>
11 Mar 2016

Italian COFUND Postdoctoral Fellow Alessandro Ruffoni (Lecco, 1985) joins the abundant group of athlete-scientists at IRB Barcelona. In January, this pharmaceutical chemist from the University of Milan took up his joint research position in Antoni Riera’s Asymmetric Synthesis’ Lab and Xavier Salvatella’s Molecular Biophysics Lab. He also has a past as a competitive runner in Italy and elsewhere: last year he embarked on a personal challenge to run from an altitude of 1800m to 3000m in the...

14 Jul 2015

The newspaper “El Periódico de Catalunya” has echoed the award ceremony of the 77 grants given by the “Obra Social La Caixa” foundation to support doctoral students. This grant programme aims to retain Spanish students and attract international students with talent for research, both for Spanish universities and Severo Ochoa centres. In this edition, IRB Barcelona students Jürgen Walther, Craig Donoghue, Elzbieta Szulc, and Lada Murcia received these awards.

16 Feb 2015

Craig Donoghue, PhD student in the Research Unit on Asymmetric Synthesis at IRB Barcelona, has been interviewed by the Royal Society of Chemistry. Donoghue explains his experience in industry and research, which has led him to appreciate the importance of knowledge transfer from research centres to society. The interview is part of the “175 Faces of Chemistry” series, which commemorates the 175th anniversary of this organisation.

Read the interview in the Royal Society of Chemistry

28 Mar 2012

Feature article on the work being performed by María Macias and Antoni Riera at IRB Barcelona on the hormone somatostatin and that has been published in Ang. Chemie.

Read the festure article Madri+d (PDF in Spanish)

Read the article online at...

<p>Structure of the somatostatina analogue synthesized in Riera's Lab</p>
20 Jan 2012

For several decades the pharmaceutical industry has been interested in achieving peptide analogues —similar molecules with improved properties— of the natural hormone somatostatin. This hormone and another two analogue compounds, octreotide and lanreotide, are used for the treatment of several kinds of neoplasia, such cancer of the thyroid, pancreas and prostate, in diseases associated with the growth hormone, for example in gigantism, and in digestive hemorrhages. Headed by...

16 Sep 2010

The online magazine Qestudio, which aims to guide young people on their choice of training, highlights in an interview the career of the young researcher Nuria Aiguabella. IRB Barcelona has a large and active PhD student community and annually makes a public call for grants addressed to graduate students who wish to perform their doctoral studies in the centre. By obtaining this grant, Nuria has become a member of IRB Barcelona and has begun working with prostaglandins in the Asymmetric Synthesis Group, headed by Antoni Riera. The interview covers topics ranging from why she opted for chemistry at the end of secondary school school to what motivates her in the day-to-day activities of...

23 Nov 2006

Read the opinion article